Telehealth and CGM for Diverse Diabetic Patients
Continues glucose monitoring with remote glucose monitoring for 90 days
Diabetes Mellitus+2
+ Endocrine System Diseases
+ Metabolic Diseases
Supportive Care Study
Summary
Study start date: April 1, 2025
Actual date on which the first participant was enrolled.This study is designed to see if using a Continuous Glucose Monitoring (CGM) device, along with a Remote Patient Monitoring (RPM) program, can help people with diabetes manage their blood sugar better and avoid returning to the hospital. It focuses on people whose diabetes is not well controlled and who have recently left the hospital. By utilizing these innovative monitoring tools, the study aims to find out if more consistent and real-time tracking of blood sugar can lead to better health outcomes, like lower Hemoglobin A1c levels, fewer hospital readmissions, and improved overall health. Participants in the study are divided into two groups: one group receives the usual diabetes care, while the other group gets a Dexcom G7 CGM device and support from specially trained nurses. These nurses check the participants' glucose readings every day. The study lasts for 90 days, during which it measures how well the participants' blood sugar levels are controlled and how often they need to go back to the hospital. This approach hopes to provide insights into whether continuous monitoring and remote support can effectively enhance diabetes management.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.208 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives